Related references
Note: Only part of the references are listed.Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemia
Shih-Shih Chen et al.
HEMATOLOGICAL ONCOLOGY (2023)
The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
Jie Xu et al.
FRONTIERS IN IMMUNOLOGY (2023)
Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events
Jiao Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
The role of BTK inhibitors on the tumor microenvironment in CLL
Joel McCay et al.
LEUKEMIA & LYMPHOMA (2022)
A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature
Francesca Bacchiarri et al.
CLINICAL CASE REPORTS (2022)
CXCL9 Predicts the Risk of Osteoporotic Hip Fracture in a Prospective Cohort of Chinese Men-A Matched Case-Control Study
Quang Tien Phan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Cytokine-mediated immunomodulation of osteoclastogenesis
Pengcheng Zhou et al.
BONE (2022)
Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
Yanyan Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
Giovanna Merchand-Reyes et al.
JOURNAL OF IMMUNOLOGY (2022)
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines
Paolo Giannoni et al.
HAEMATOLOGICA (2021)
Influences of the IL-6 cytokine family on bone structure and function
Natalie A. Sims
CYTOKINE (2021)
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
Stefania Fiorcari et al.
CELLS (2021)
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia
Isabelle G. Solman et al.
LEUKEMIA RESEARCH (2021)
Exploiting bone niches: progression of disseminated tumor cells to metastasis
Aaron M. Muscarella et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes
Sining Zhu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
Maissa Mhibik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients
Wioleta Kowalska
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2020)
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
Zezheng Liu et al.
CLINICAL INTERVENTIONS IN AGING (2020)
The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis
Lan Yan et al.
FRONTIERS IN IMMUNOLOGY (2020)
High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
Michal Zarobkiewicz et al.
CANCERS (2020)
Implication of the Association of Fibrinogen Citrullination and Osteoclastogenesis in Bone Destruction in Rheumatoid Arthritis
Ji Soo Kim et al.
CELLS (2020)
Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells
Oana Mesaros et al.
BIOMEDICINES (2020)
Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential
Jihyun Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
Huan Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade
Jeong-Tae Yeon et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Chemokines in Physiological and Pathological Bone Remodeling
Laura J. Brylka et al.
FRONTIERS IN IMMUNOLOGY (2019)
A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption
Nitin Kumar Pokhrel et al.
JOURNAL OF PERIODONTOLOGY (2019)
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
Danielle Harmer et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
Yuko Ariza et al.
BONE REPORTS (2019)
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
K. Kondo et al.
LEUKEMIA (2018)
Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions
Xose S. Puente et al.
BLOOD (2018)
Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity
Matthew C. Walsh et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Regulation of Osteoclast Differentiation by Cytokine Networks
Dulshara Sachini Amarasekara et al.
IMMUNE NETWORK (2018)
Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility
Keith L. Kirkwood et al.
IMMUNOLOGICAL INVESTIGATIONS (2018)
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts
Marina Bolzoni et al.
HAEMATOLOGICA (2017)
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
Martijn H. A. van Attekum et al.
HAEMATOLOGICA (2017)
Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro
Harry C. Blair et al.
TISSUE ENGINEERING PART B-REVIEWS (2017)
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway
Cecilia Marini et al.
SCIENTIFIC REPORTS (2017)
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts
Marina Bolzoni et al.
HAEMATOLOGICA (2017)
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
Martijn H. A. van Attekum et al.
HAEMATOLOGICA (2017)
Chronic lymphocytic leukaemia
Thomas J. Kipps et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
Carsten U. Niemann et al.
CLINICAL CANCER RESEARCH (2016)
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway
Manoj K. Kashyap et al.
ONCOTARGET (2016)
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib
Evgenii Shumilov et al.
LEUKEMIA & LYMPHOMA (2016)
Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction
Mercedes Borge et al.
LEUKEMIA & LYMPHOMA (2016)
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Stefania Fiorcari et al.
ONCOTARGET (2016)
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
Sara Serra et al.
BLOOD ADVANCES (2016)
Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
F. Boissard et al.
BLOOD CANCER JOURNAL (2015)
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Valentina Audrito et al.
BLOOD (2015)
The Bone Marrow Endosteal Niche: How Far from the Surface?
Eric Cordeiro-Spinetti et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells
Loris De Cecco et al.
PLOS ONE (2015)
Effect of TNFα on osteoblastogenesis from mesenchymal stem cells
Shigeru Kotake et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Regina Jitschin et al.
BLOOD (2014)
The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss
Masahiro Shinohara et al.
BONE (2014)
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages
Paolo Giannoni et al.
HAEMATOLOGICA (2014)
The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation
Shanmugam Muruganandan et al.
IUBMB LIFE (2014)
Adult Advanced Chronic Lymphocytic Leukemia: Computational Analysis of Whole-Body CT Documents a Bone Structure Alteration
Francesco Fiz et al.
RADIOLOGY (2014)
Circulating microenvironment of CLL: Are nurse-like cells related to tumor-associated macrophages?
Agata A. Filip et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options
Valentina Audrito et al.
CANCER LETTERS (2013)
Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
Anandi Sawant et al.
CANCER RESEARCH (2013)
RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia
Benjamin Joachim Schmiedel et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells as Osteoclast Progenitors: A Novel Target for Controlling Osteolytic Bone Metastasis
Anandi Sawant et al.
CANCER RESEARCH (2013)
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation
Rossana Maffei et al.
HAEMATOLOGICA (2013)
Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
Vesa Lindstrom et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Junling Zhuang et al.
PLOS ONE (2012)
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
Sabrina Danilin et al.
ONCOIMMUNOLOGY (2012)
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
Xiao-Jie Yan et al.
BLOOD (2011)
Nurse-like cells show deregulated expression of genes involved in immunocompetence
Nupur Bhattacharya et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia
C. Scielzo et al.
LEUKEMIA (2011)
Matrix-embedded cells control osteoclast formation
Jinhu Xiong et al.
NATURE MEDICINE (2011)
The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact
Percy Schroettner et al.
ANNALS OF HEMATOLOGY (2010)
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
Jan A. Burger
SEMINARS IN CANCER BIOLOGY (2010)
CD16 (FcR gamma III) as a potential marker of osteoclast precursors in psoriatic arthritis
Yahui Grace Chiu et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Cold-Activated Brown Adipose Tissue in Healthy Men
Wouter D. van Marken Lichtenbelt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals
Masahiro Shinohara et al.
CELL (2008)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia
N Tsukada et al.
BLOOD (2002)
Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect
HA Papadaki et al.
BLOOD (2002)
Expression and function of wingless and frizzled homologs in rheumatoid arthritis
M Sen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
